Cargando…

Changes in Function and Dynamics in Hepatic and Splenic Macrophages in Non-Alcoholic Fatty Liver Disease

BACKGROUND: The aim of this study was to investigate the populations and functions of hepatic and splenic macrophages (Mfs) in non-alcoholic fatty liver disease (NAFLD). MATERIALS AND METHODS: Experiment 1: Wild-type and STAM(®) mice were given chow or high-fat diets for designated periods. In isola...

Descripción completa

Detalles Bibliográficos
Autores principales:	Fukushima, Hisataka, Kono, Hiroshi, Hirayama, Kazuyoshi, Akazawa, Yoshihiro, Nakata, Yuuki, Wakana, Hiroyuki, Fujii, Hideki
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2020
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7457821/ https://www.ncbi.nlm.nih.gov/pubmed/32922061 http://dx.doi.org/10.2147/CEG.S248635

Ejemplares similares

Expression of podoplanin in stromal fibroblasts plays a pivotal role in the prognosis of patients with pancreatic cancer
por: Hirayama, Kazuyoshi, et al.
Publicado: (2017)

Macrophage colony-stimulating factor expressed in non-cancer tissues provides predictive powers for recurrence in hepatocellular carcinoma
por: Kono, Hiroshi, et al.
Publicado: (2016)

Hepatic ductoplasty for iatrogenic Bismuth type 2 bile duct stricture: A case report
por: Hirotaka, Okamoto, et al.
Publicado: (2018)

Gentiana scabra Restrains Hepatic Pro-Inflammatory Macrophages to Ameliorate Non-Alcoholic Fatty Liver Disease
por: Zheng, Yiyuan, et al.
Publicado: (2022)

The Anti-Adiposity Mechanisms of Ampelopsin and Vine Tea Extract in High Fat Diet and Alcohol-Induced Fatty Liver Mouse Models
por: Wu, Jianbo, et al.
Publicado: (2022)

Macrophages and the development and progression of non-alcoholic fatty liver disease
por: Alabdulaali, Bader, et al.
Publicado: (2023)

The Dipeptidyl Peptidase-4 Inhibitor Teneligliptin Attenuates Hepatic Lipogenesis via AMPK Activation in Non-Alcoholic Fatty Liver Disease Model Mice
por: Ideta, Takayasu, et al.
Publicado: (2015)

Gene expression in nontumoral liver tissue and recurrence-free survival in hepatitis C virus-positive hepatocellular carcinoma
por: Tsuchiya, Masato, et al.
Publicado: (2010)

Liver macrophages and inflammation in physiology and physiopathology of non‐alcoholic fatty liver disease
por: Thibaut, Ronan, et al.
Publicado: (2021)

Macrophages in obesity and non-alcoholic fatty liver disease: Crosstalk with metabolism
por: Lefere, Sander, et al.
Publicado: (2019)

Hepatic Macrophage as a Key Player in Fatty Liver Disease
por: Xu, Liyun, et al.
Publicado: (2021)

Non‐alcoholic fatty liver disease in patients with autoimmune hepatitis
por: Takahashi, Atsushi, et al.
Publicado: (2018)

Complements are involved in alcoholic fatty liver disease, hepatitis and fibrosis
por: Lin, Cheng-Jie, et al.
Publicado: (2018)

Challenges in the hepatic histopathology in non-alcoholic fatty liver disease
por: Brunt, Elizabeth M, et al.
Publicado: (2017)

Non-Alcoholic Fatty Liver Disease and Extra-Hepatic Cancers
por: Sanna, Claudia, et al.
Publicado: (2016)

Macrophage Function in the Pathogenesis of Non-alcoholic Fatty Liver Disease: The Mac Attack
por: Oates, Jarren R., et al.
Publicado: (2019)

The role of hepatic macrophages in nonalcoholic fatty liver disease and nonalcoholic steatohepatitis
por: Cha, Ji-Young, et al.
Publicado: (2018)

Mechanisms of hepatic triglyceride accumulation in non-alcoholic fatty liver disease
por: Kawano, Yuki, et al.
Publicado: (2013)

Nonalcoholic fatty liver disease and alcohol-related liver disease: From clinical aspects to pathophysiological insights
por: Ikejima, Kenichi, et al.
Publicado: (2020)

Novel Ultrasonographic Fatty Liver Indicator Can Predict Hepatitis in Children With Non-alcoholic Fatty Liver Disease
por: Liu, Hsien-Kuan, et al.
Publicado: (2019)

Novel Action of Carotenoids on Non-Alcoholic Fatty Liver Disease: Macrophage Polarization and Liver Homeostasis
por: Ni, Yinhua, et al.
Publicado: (2016)

Chronic Alcohol Consumption is Inversely Associated with Insulin Resistance and Fatty Liver in Japanese Males
por: Akahane, Takemi, et al.
Publicado: (2020)

Macrophages and scavenger receptors in obesity‐associated non‐alcoholic liver fatty disease (NAFLD)
por: Kragh Petersen, Sine, et al.
Publicado: (2020)

Hepatic and Splenic Volumetry Could Be Used as an Imaging Parameter to Evaluate Fibrosis Grades of the Diffuse Liver Disease Including Nonalcoholic Fatty Liver Disease
por: Jeong, Woo Kyoung
Publicado: (2017)

Tuberculosis Presenting as Hepatic and Splenic Microabscesses
por: Gaba, Saurabh, et al.
Publicado: (2020)

Hepatic Unsaturated Fatty Acids Are Linked to Lower Degree of Fibrosis in Non-alcoholic Fatty Liver Disease
por: Fridén, Michael, et al.
Publicado: (2022)

Liquid Biopsy for the Diagnosis of Viral Hepatitis, Fatty Liver Steatosis, and Alcoholic Liver Diseases
por: Shabangu, Ciniso Sylvester, et al.
Publicado: (2020)

Covalent Inhibition of Pyruvate Kinase M2 Reprograms Metabolic and Inflammatory Pathways in Hepatic Macrophages against Non-alcoholic Fatty Liver Disease
por: Fan, Ni, et al.
Publicado: (2022)

Ultrastructural Changes of Hepatic Stellate Cells in the Space of Disse in Alcoholic Fatty Liver
por: Han, Nam-Ik, et al.
Publicado: (2001)

Molecular mechanisms of hepatic lipid accumulation in non-alcoholic fatty liver disease
por: Ipsen, David Højland, et al.
Publicado: (2018)

The Vicious Circle of Hepatic Glucagon Resistance in Non-Alcoholic Fatty Liver Disease
por: Galsgaard, Katrine D.
Publicado: (2020)

Role of Hepatic Aryl Hydrocarbon Receptor in Non-Alcoholic Fatty Liver Disease
por: Patil, Nikhil Y., et al.
Publicado: (2023)

The Role of Insulin Resistance and Diabetes in Nonalcoholic Fatty Liver Disease
por: Fujii, Hideki, et al.
Publicado: (2020)

Role of gp91(phox) in hepatic macrophage programming and alcoholic liver disease
por: Wang, Meng, et al.
Publicado: (2017)

The contradictory roles of macrophages in non-alcoholic fatty liver disease and primary liver cancer—Challenges and opportunities
por: Kohlhepp, Marlene Sophia, et al.
Publicado: (2023)

Therapeutic targeting of adipose tissue macrophages ameliorates liver fibrosis in non-alcoholic fatty liver disease
por: Martínez–Sánchez, Celia, et al.
Publicado: (2023)

Pemafibrate, a selective PPARα modulator, prevents non-alcoholic steatohepatitis development without reducing the hepatic triglyceride content
por: Sasaki, Yusuke, et al.
Publicado: (2020)

Splenic macrophages as the source of bacteraemia during pneumococcal pneumonia
por: Carreno, David, et al.
Publicado: (2021)

Nonalcoholic Fatty Liver Disease Progression in Rats is Accelerated by Splenic Regulation of Liver PTEN/AKT
por: Wang, Ziming, et al.
Publicado: (2015)

Macrophage-derived thrombospondin 1 promotes obesity-associated non-alcoholic fatty liver disease
por: Gwag, Taesik, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_h465fjd4ld0rlfhvk7al59oigt